Success Metrics

Clinical Success Rate
75.0%

Based on 6 completed trials

Completion Rate
75%(6/8)
Active Trials
2(12%)
Results Posted
33%(2 trials)
Terminated
2(12%)

Phase Distribution

Ph not_applicable
7
41%
Ph phase_1
1
6%
Ph phase_4
1
6%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
Phase 4Post-market surveillance
1(11.1%)
N/ANon-phased studies
7(77.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

6 of 9 finished

Non-Completion Rate

33.3%

3 ended early

Currently Active

2

trials recruiting

Total Trials

17

all time

Status Distribution
Active(2)
Completed(6)
Terminated(3)
Other(6)

Detailed Status

Completed6
unknown6
Terminated2
Recruiting1
Active, not recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
17
Active
2
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (11.1%)
Phase 41 (11.1%)
N/A7 (77.8%)

Trials by Status

recruiting16%
completed635%
terminated212%
unknown635%
active_not_recruiting16%
withdrawn16%

Recent Activity

Clinical Trials (17)

Showing 17 of 17 trials
NCT07366723Not Applicable

The Role of cardIac magNeTic rEsonance in surGical Decision Making in Patients With Severe pRimAry miTral rEgurgitation

Active Not Recruiting
NCT06255457

Ventricular Arrhythmias in Patients Undergoing Mitral Valve Surgery

Recruiting
NCT03587688

Registry for Mitral Valve Surgery at Department of Cardiac Surgery University Hospital of Basel/ Switzerland

Completed
NCT04813692

Mechanical Complications of Acute Myocardial Infarction During COVID-19 Pandemics

Completed
NCT05774795

LOng-Term Fate of Moderate Aortic Regurgitation Left Untreated at the Time of Mitral Valve Surgery

Completed
NCT05403840

Haemodynamics of Mitral Regurgitation Reduction

Unknown
NCT03798015

Neurologic Outcome After Mitral Valve Surgery

Withdrawn
NCT01558635Not Applicable

Evaluation of the Cardioblate CryoFlex Surgical Ablation System in Longstanding Persistent Atrial Fibrillation

Terminated
NCT01288976

ACCESS-Europe A Two-Phase Observational Study of the MitraClip® System in Europe

Completed
NCT03012178

MRI as a Predictor of Outcomes in Patients Undergoing Mitral Valve Surgery

Unknown
NCT02047279Not Applicable

Ablation and Left Atrium Reduction During Mitral Valve Surgery for Atrial Fibrillation

Completed
NCT02371512Not Applicable

A Multicenter, Randomized, Controlled Study to Assess Mitral vAlve reconsTrucTion for advancEd Insufficiency of Functional or iscHemic ORigiN

Unknown
NCT03129737Not Applicable

PROphylactic triCuspID Annuloplasty in Patients With Dilated Tricuspid Annulus

Unknown
NCT02534155Phase 4

High and Intermediate Risk Degenerative Mitral Regurgitation Treatment: A Trial Comparing MitraClip® to Surgical Therapy

Terminated
NCT02818166Not Applicable

Magnetic Resonance Imaging for Cerebral Embolization During Minimal Invasive Mitral Valve Surgery

Unknown
NCT02374229Phase 1

Ablation of the Pulmonary Artery With High Pulmonary Hypertension During Mitral Valve Surgery

Unknown
NCT02054221Not Applicable

Surgical Treatment of Hypertrophic Obstructive Cardiomyopathy With Severe Mitral Insufficiency.

Completed

All 17 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
17